Karen Vousden
British medical researcher
Karen Heather Vousden (born 19 July 1957) is a British medical researcher. She is known for her work on the tumour suppressor protein, p53, and in particular her discovery of the important regulatory role of Mdm2, an attractive target for anti-cancer agents.2
From Wikipedia’s article on Karen Vousden (this version), CC BY-SA 4.0.
Born Jul 19, 1957.1
About
From 2003 to 2016, she was the director of the Cancer Research UK Beatson Institute in Glasgow, UK, moving back to London in 2016 to take up the role of Chief Scientist at CRUK and Group Leader at the Francis Crick Institute.
From Wikipedia’s article on Karen Vousden, shared under CC BY-SA 4.0.2
Companies
- Faeth Therapeutics, Inc.Board member Sep 15, 2026 to now16
- Bristol-Myers SquibbBoard member Jan 1, 2018 to now17
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Faeth Therapeutics, Inc. FTH42,631 shares18$831.9K at $19.52Sep 15, 2026
As of each latest filing. The line shows shares held over time.
Early life and education
- Date not recordedQueen Mary University of London3
- Date not recordedMayfield Grammar School, Gravesend3
After attending Gravesend Grammar School for Girls, Vousden gained a Bachelor of Science degree in genetics and microbiology (1978) and a PhD from Queen Mary College, University of London on the use of suppressor gene mutations to study transfer RNA redundancy in the fungus Coprinus.
From Wikipedia’s article on Karen Vousden (this version), CC BY-SA 4.0.
Career
Occupation: biologist.8
- Since 2018Board member, Bristol-Myers Squibb7
- Date not recordedWorked at Institute of Cancer Research4 5
- Date not recordedWorked at Francis Crick Institute4 6
Vousden's early postdoctoral research positions were with Chris Marshall at the Institute of Cancer Research, London, UK (1981–85) and Douglas Lowy at the National Cancer Institute, Bethesda, United States (1985–87).
From 1987 to 1995, she led the Human Papillomavirus Group at the Ludwig Institute for Cancer Research, London, UK. In 1995, she joined the National Cancer Institute in Frederick, USA, serving successively as head of the Molecular Carcinogenesis section of the ABL-Basic Research Program (1995–97), director of the Molecular Virology and Carcinogenesis Laboratory (1997–98), interim director of the ABL-Basic Research Program (1998–99) and chief of the Regulation of Cell Growth Laboratory, Division of Basic Sciences (1999–2002).
From 2003 to 2016, she was the director of the Cancer Research UK Beatson Institute in Glasgow, UK, where she oversaw a £15 million expansion. She also led the institute's Tumour Suppression research group. She also served on the Life Sciences jury for the Infosys Prize in 2014.
Since 2016, she has moved back to London to take up the role of CRUK Chief Scientist and Group Leader at the Francis Crick Institute. In 2018, she was elected a foreign associate of the National Academy of Sciences.
From Wikipedia’s article on Karen Vousden (this version), CC BY-SA 4.0.
Personal life
Awards
- 2017Fellow of the AACR Academy11
- 2013Fellow of the American Association for the Advancement of Science11 15
- 2006Fellow of the Academy of Medical Sciences11 14
- 2004Fellow of the Royal Society of Edinburgh11 13
- 2003Fellow of the Royal Society11 12
- Date not recordedCommander of the Order of the British Empire11
- Date not recordedEMBO Membership11
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataKaren Vousden on Wikidata
- 2WikipediaKaren Vousden on Wikipedia
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12Wikidataaward, as reported
- 13Wikidataaward, as reported
- 14Wikidataaward, as reported
- 15Wikidataaward, as reported
- 16
- 17Wikidata and SEC EDGARBristol-Myers Squibb, Board member
- 18